Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Keybanc Maintains Overweight on ICU Medical, Lowers Price Target to $225

Keybanc analyst Matthew Mishan maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers the price target from $230 to $225.
byBenzinga Newsdesk
August 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Keybanc analyst Matthew Mishan maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers the price target from $230 to $225.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

BetMGM Business Update; Delivery Of 2023 Guidance, Reaching The Upper End Of $1.8B-$2B Revenue And Achieving EBITDA Profitability In The Second Half; Setting A Target Of Approximately $500M EBITDA In 2026 For BetMGM

By Benzinga Newsdesk
December 4, 10:08 AM
Business on Track with Key Enhancements to Drive Sustainable GrowthLAS VEGAS, Dec. 4, 2023 /PRNewswire/ -- BetMGM, LLC ("BetMGM"), one of the leading sports betting and iGaming operators across the U.S., jointly owned by

MGM